117
Participants
Start Date
September 1, 2020
Primary Completion Date
June 8, 2022
Study Completion Date
June 20, 2022
PXL065
PXL065 oral tablet
Placebo oral tablet
Placebo oral tablet
Study site 27, East Syracuse
Study site 14, Fayetteville
Study site 29, Summerville
Study site 08, Port Orange
Study site 15, Boca Raton
Study site 31, Fort Myers
Study site 01, Sarasota
Study site 30, Clarksville
Study site 25, Chattanooga
Study Site 02, Germantown
Study site 10, Jackson
Study site 24, Flowood
Study site 28, West Des Moines
Study site 18, Kansas City
Pinnacle Clinical Research (Study site 20), San Antonio
Study site 09, Edinburg
Study site 23, Edinburg
Study site 19, Austin
Study site 11, Chandler
Study site 12, Glendale
Study site 13, Tucson
Study site 21, Tucson
Study site 05, Los Angeles
Study site 04, Huntington Park
Study site 06, Panorama City
Study site 17, Chula Vista
Study site 07, Santa Ana
Study site 22, Orange
Study site 16, Fresno
Lead Sponsor
Poxel SA
INDUSTRY